Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Assunto principal
Intervalo de ano de publicação
1.
Clin Ter ; 151(1): 37-43, 2000.
Artigo em Italiano | MEDLINE | ID: mdl-10822880

RESUMO

It is of primary importance for the clinical cardiologist to keep in mind the parameters allowing an adequate prognostic stratification in post-infarct patients in view of making the best diagnostic and therapeutic choices. A diagnostic strategy, based on a pathophysiologic approach, should evaluate four aspects: spontaneous and stress-induced ischemia, myocardial viability, and ventricular arrhythmias. Spontaneous ischemia has an undefined prognostic value, especially in the thrombolytic era; therefore it seems reasonable to perform invasive procedures in patients who are not stabilized by an adequate medical therapy or with large jeopardized areas. In asymptomatic patients, a provocative stress test allows a more articulated decisional iter. It is preferably to perform the test by the most physiological exercise EKG, together with the echocardiographic imaging, after the acute phase. It has a high negative predictive value, but a low positive predictive value. The detection of myocardial viability is frequently performed, mainly in patients with large post-ischemic myocardial dysfunction. Among all the proposed methods, the echo-dobutamine test mainly allows to estimate patients in whom revascularization may result in more benefit. The role of ventricular arrhythmias as an independent prognostic factor is debated and has to be always considered in relationship to other parameters, particularly left ventricular function. Regarding the therapeutic strategy, the indications from recent trials, related to antithrombotic drugs, beta-blockers, ACE-inhibitors, nitrates, Ca-blockers and antiarrhythmic drugs, are emphasized.


Assuntos
Infarto do Miocárdio/complicações , Infarto do Miocárdio/tratamento farmacológico , Antagonistas Adrenérgicos beta/uso terapêutico , Fatores Etários , Angina Pectoris/etiologia , Angina Pectoris/fisiopatologia , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Arritmias Cardíacas/etiologia , Bloqueadores dos Canais de Cálcio/uso terapêutico , Teste de Esforço , Humanos , Infarto do Miocárdio/fisiopatologia , Isquemia Miocárdica/etiologia , Isquemia Miocárdica/fisiopatologia , Prognóstico , Medição de Risco , Terapia Trombolítica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA